花红药业品牌怎么样 申请店铺
专注于女性健康事业，提供专业化的优质药品和服务，集药材种植/科研/生产、销售为一体的企业
广西壮族自治区花红药业股份有限公司是集药材种植、科研、生产、销售为一体的企业，始建于20世纪70年代初。2002年完成国有改制，与上海复星医药进行合资合作；2005年完成股份制改制；2006年至今，根据大健康发展战略，通过独资、合资、并购等方式，逐渐发展形成药品经营、植物药品生产销售及女性健康服务等产业结构，相继成立花红医药、金松药业等子公司。
花红药业拥有中成药54个品种，21个品种入选《国家基本医疗保险药品目录》，花红片（颗粒、胶囊）入选《2012版国家基本药物目录》，花红片、花红胶囊、花红颗粒、消肿止痛酊、葛根芩连丸、解毒生肌膏等6个产品列入《国家基本医疗保险、工伤保险和生育保险药品目录（2017年版）》。
根据花红战略规划，公司不断加大新产品研发投入。在女性五期（经、孕、产、乳、更）及其它中药研制方面与中国医学科学院药用植物研究所、沈阳药科大学、广西食品药品检验所等机构保持合作，一批科研成果将投入市场。
花红药业从原材料采购、生产制控、售后服务、不良反应监测全程严格执行GMP管理，以高于国家法定标准的企业内控标准，为患者提供高品质的药品。
面向未来，花红药业继续奉行“关心健康，爱护家庭”的宗旨，秉承“坦诚、开放、严谨、感恩”的企业理念，专注于女性健康事业，为改善和提高女性健康水平，提供专业化的优质药品和服务，发展以品牌为核心的妇科产品群，努力成为中国乃至全球女性用药的女性健康专家。
Focusing on women's health, providing professional high-quality drugs and services, Guangxi Zhuang Autonomous Region Huahong Pharmaceutical Co., Ltd. is an enterprise integrating the cultivation, scientific research, production and sales of medicinal materials, which was founded in the early 1970s. In 2002, the state-owned restructuring was completed, and the joint-venture cooperation with Shanghai Fosun Pharmaceutical was carried out; in 2005, the joint-stock restructuring was completed; since 2006, according to the great health development strategy, through sole investment, joint venture, merger and acquisition, the industrial structure of drug management, plant drug production and sales, and women's health service was gradually developed, and Huahong pharmaceutical, Jinsong pharmaceutical and other subsidiaries were successively established. Huahong pharmaceutical industry has 54 varieties of Chinese patent medicines, 21 of which are listed in the catalogue of national basic medical insurance drugs, Huahong tablets (granules and capsules) are listed in the catalogue of national basic drugs 2012, and 6 products, such as Huahong tablets, Huahong capsules, Huahong granules, Xiaozhong Zhitong tincture, Gegen Qinlian pills, Jiedu Shengji cream, are listed in the national basic medical insurance, work injury insurance and maternity insurance Drug catalogue (2017 Edition). According to Huahong's strategic plan, the company continues to increase investment in new product research and development. In the research and development of women's five phases (menstruation, pregnancy, childbirth, milk and replacement) and other traditional Chinese medicines, we have maintained cooperation with the Institute of medicinal plants of the Chinese Academy of Medical Sciences, Shenyang Pharmaceutical University, Guangxi food and Drug Inspection Institute and other institutions, and a number of scientific research achievements will be put into the market. Huahong pharmaceutical industry strictly implements GMP management in the whole process of raw material procurement, production control, after-sales service and adverse reaction monitoring, so as to provide high-quality drugs for patients with internal control standards higher than the national legal standards. Facing the future, Huahong pharmaceutical continues to adhere to the tenet of "caring for health, caring for family", adheres to the enterprise philosophy of "honesty, openness, preciseness and gratitude", focuses on women's health cause, provides professional high-quality drugs and services for improving and improving women's health level, develops the gynaecological product group with brand as the core, and strives to become the drug for women in China and even in the world Female health specialist.
本文链接： https://brand.waitui.com/bb5dd20ac.html 联系电话：0772-3993606,3993569
浙公网安备 33011802001999号
